|
Clinical Trials and Observations
Citations 31-40 of 2742 total displayed.
|
Past content
(since May 1998):
|
Karyotype-specific microRNA signature in chronic lymphocytic leukemia
- Rosa Visone, Laura Z. Rassenti, Angelo Veronese, Cristian Taccioli, Stefan Costinean, Baltazar D. Aguda, Stefano Volinia, Manuela Ferracin, Jeff Palatini, Veronica Balatti, Hansjuerg Alder, Massimo Negrini, Thomas J. Kipps, and Carlo M. Croce
Blood 2009; 114: 3872-3879.
[Abstract]
[Full text]
[PDF]
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
- John Koreth, Kristen E. Stevenson, Haesook T. Kim, Michael Garcia, Vincent T. Ho, Philippe Armand, Corey Cutler, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer, and Edwin P. Alyea, III
Blood 2009; 114: 3956-3959.
[Abstract]
[Full text]
[PDF]
How I treat ADA deficiency
- H. Bobby Gaspar, Alessandro Aiuti, Fulvio Porta, Fabio Candotti, Michael S. Hershfield, and Luigi D. Notarangelo
Blood 2009; 114: 3524-3532.
[Abstract]
[Full text]
[PDF]
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
- Kerry J. Savage, Nathalie A. Johnson, Susana Ben-Neriah, Joseph M. Connors, Laurie H. Sehn, Pedro Farinha, Douglas E. Horsman, and Randy D. Gascoyne
Blood 2009; 114: 3533-3537.
[Abstract]
[Full text]
[PDF]
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
- Luca Malcovati, Matteo G. Della Porta, Daniela Pietra, Emanuela Boveri, Andrea Pellagatti, Anna Gallì, Erica Travaglino, Angela Brisci, Elisa Rumi, Francesco Passamonti, Rosangela Invernizzi, Laura Cremonesi, Jacqueline Boultwood, James S. Wainscoat, Eva Hellström-Lindberg, and Mario Cazzola
Blood 2009; 114: 3538-3545.
[Abstract]
[Full text]
[PDF]
Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men
- Bas de Laat, Philip G. de Groot, Ronald H. W. M. Derksen, Rolf T. Urbanus, Koen Mertens, Frits R. Rosendaal, and Carine J. M. Doggen
Blood 2009; 114: 3656-3661.
[Abstract]
[Full text]
[PDF]
How I monitor residual disease in chronic myeloid leukemia
- Jerald P. Radich
Blood 2009; 114: 3376-3381.
[Abstract]
[Full text]
[PDF]
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
- Barbara F. Eichhorst, Raymonde Busch, Stephan Stilgenbauer, Martina Stauch, Manuela A. Bergmann, Matthias Ritgen, Nicole Kranzhöfer, Robert Rohrberg, Ulrike Söling, Oswald Burkhard, Anne Westermann, Valentin Goede, Carmen D. Schweighofer, Kirsten Fischer, Anna-Maria Fink, Clemens M. Wendtner, Günter Brittinger, Hartmut Döhner, Bertold Emmerich, Michael Hallek, and the German CLL Study Group (GCLLSG)
Blood 2009; 114: 3382-3391.
[Abstract]
[Full text]
[PDF]
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
- Maria E. Figueroa, Lucy Skrabanek, Yushan Li, Anchalee Jiemjit, Tamer E. Fandy, Elisabeth Paietta, Hugo Fernandez, Martin S. Tallman, John M. Greally, Hetty Carraway, Jonathan D. Licht, Steven D. Gore, and Ari Melnick
Blood 2009; 114: 3448-3458.
[Abstract]
[Full text]
[PDF]
Cerebrovascular reserve capacity is impaired in patients with sickle cell disease
- Erfan Nur, Yu-Sok Kim, Jasper Truijen, Eduard J. van Beers, Shyrin C. A. T. Davis, Dees P. Brandjes, Bart J. Biemond, and Johannes J. van Lieshout
Blood 2009; 114: 3473-3478.
[Abstract]
[Full text]
[PDF]
|
|
